COMT-by-sex interaction effect on psychosis proneness

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  De Castro Catala, Marta ^a   Barrantes Vidal, Neus ^b,c,d,e   Sheinbaum, Tamara ^b   Moreno Fortuny, Artal ^a,f   Kwapil, Thomas R ^c   Rosa, Araceli ^a,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^d Sant Pere Claver Fundació Sanitària ^*  (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; COMT PROTEIN, HUMAN;

ADULT; ARTICLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PHENOTYPE; PREFRONTAL CORTEX; PSYCHOMETRY; PSYCHOSIS; SCORING SYSTEM; SEX DIFFERENCE; YOUNG ADULT; ALLELE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; SCHIZOPHRENIA; SEXUAL DEVELOPMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84924097977     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/829237     Document Type: Article

References (55)

1. K. P. Cosgrove, C. M. Mazure, and J. K. Staley, "Evolving knowledge of sex differences in brain structure, function, and chemistry," Biological Psychiatry, vol. 62, no. 8, pp. 847-855, 2007.
2. A. Aleman, R. S. Kahn, and J.-P. Selten, "Sex differences in the risk of schizophrenia: evidence frommeta-analysis," Archives of General Psychiatry, vol. 60, no. 6, pp. 565-571, 2003.
3. L. Cahill, "Why sex matters for neuroscience," Nature Reviews Neuroscience, vol. 7, no. 6, pp. 477-484, 2006.
4. K. L. Davis, R. S. Kahn,G.Ko, andM.Davidson, "Dopamine in schizophrenia: a reviewand reconceptualization,"TheAmerican Journal of Psychiatry, vol. 148, no. 11, pp. 1474-1486, 1991.
5. Y. Wang, Y. Fang, Y. Shen, and Q. Xu, "Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia," Psychiatry Research, vol. 179, no. 2, pp. 147-150, 2010.
6. M. Laruelle, "Schizophrenia: fromdopaminergic to glutamatergic interventions," CurrentOpinion in Pharmacology, vol. 14,no. 1, pp. 97-102, 2014.
7. P. J. Harrison and E. M. Tunbridge, "Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders," Neuropsychopharmacology, vol. 33, no. 13, pp. 3037-3045, 2008.
8. E. M. Tunbridge and P. J. Harrison, "Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders," Current Topics in Behavioral Neurosciences, vol. 8, pp. 119-140, 2011.
9. K. A. Nolan, J. Volavka, P. Czobor et al., "Suicidal behavior in patients with schizophrenia is related to COMT polymorphism," Psychiatric Genetics, vol. 10, no. 3, pp. 117-124, 2000.
10. U. E. Lang, M. Bajbouj, T. Sander, and J. Gallinat, "Genderdependent association of the functional catechol-Omethyltransferase Val158Met genotype with sensation seeking personality trait," Neuropsychopharmacology, vol. 32, no. 9, pp. 1950-1955, 2007.
11. M. R.Munafò, L. Bowes, T. G. Clark, and J. Flint, "Lack of association of the COMT (Val158/108Met) gene and schizophrenia: a meta-analysis of case-control studies," Molecular Psychiatry, vol. 10, no. 8, pp. 765-770, 2005.
12. J. Costas, J. Sanjúan, R. Ramos-Rós et al., "Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: newdata and meta-analysis," Journal of Psychiatric Research, vol. 45, no. 1, pp. 7-14, 2011.
13. S. Shifman, M. Bronstein, M. Sternfeld et al., "A highly significant association between a COMT haplotype and schizophrenia," The American Journal of Human Genetics, vol. 71, no. 6, pp. 1296-1302, 2002.
14. A. Sazci, E. Ergul, I. Kucukali, G. Kilic, G. Kaya, and I. Kara, "Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women," Molecular Brain Research, vol. 132, no. 1, pp. 51-56, 2004.
15. J. Hoenicka, E. Garrido, G. Ponce et al., "Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia," American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 153, no. 4, pp. 948-954, 2010.
16. J. Hoenicka, E. Garrido, I. Martńez et al., "Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients," The American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, vol. 153, no. 1, pp. 79-85, 2010.
17. G. Claridge, C.McCreery, O.Mason et al., "The factor structure of 'schizotypal' traits: a large replication study," British Journal of Clinical Psychology, vol. 35, no. 1, pp. 103-115, 1996.
18. P. E. Meehl, "Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia," Journal of Personality Disorders, vol. 4, no. 1, pp. 1-99, 1990.
19. T. Kwapil and N. Barrantes-Vidal, "Schizotypal personality disorder: an integrative review," in The Oxford Handbook of Personality Disorders, pp. 437-477, Oxford University Press, Oxford, UK, 2012.
20. N. Barrantes-Vidal, G. M. Gross, T. Sheinbaum, M. Mitjavila, S. Ballespánd T. R. Kwapil, "Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms," Schizophrenia Research, vol. 145, no. 1-3, pp. 50-55, 2013.
21. T. R. Kwapil, N. Barrantes-Vidal, and P. J. Silvia, "The dimensional structure of the wisconsin schizotypy scales: factor identification and construct validity," Schizophrenia Bulletin, vol. 34, no. 3, pp. 444-457, 2008.
22. K. S.Kendler, L. Thacker, andD.Walsh, "Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia," Schizophrenia Bulletin, vol. 22, no. 3, pp. 511-520, 1996.
23. A. H. Fanous, M. C. Neale, C. O. Gardner et al., "Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy,"Molecular Psychiatry, vol. 12, no. 10, pp. 958-965, 2007.
24. N. C. Stefanis, M. Hanssen, N. K. Smirnis et al., "Evidence that three dimensions of psychosis have a distribution in the general population," Psychological Medicine, vol. 32, no. 2, pp. 347-358, 2002.
25. T. R. Kwapil, G. M. Gross, P. J. Silvia, and N. Barrantes-Vidal, "Prediction of psychopathology and functional impairment by positive and negative schizotypy in the chapmans'ten-year longitudinal study," Journal ofAbnormal Psychology, vol. 122, no. 3, pp. 807-815, 2013.
26. N. Barrantes-Vidal, K. E. Lewandowski, and T. R. Kwapil, "Psychopathology, social adjustment and personality correlates of schizotypy clusters in a large nonclinical sample," Schizophrenia Research, vol. 122, no. 1-3, pp. 219-225, 2010.
27. N. Barrantes-Vidal, C. A. Chun, I. Myin-Germeys, and T. R. Kwapil, "Psychometric schizotypy predicts psychotic-like, paranoid, and negative symptoms in daily life," Journal of Abnormal Psychology, vol. 122, no. 4, pp. 1077-1087, 2013.
28. J. van Os, R. J. Linscott, I. Myin-Germeys, P. Delespaul, and L. Krabbendam, "A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis pronenesspersistence-impairment model of psychotic disorder," Psychological Medicine, vol. 39, no. 2, pp. 179-195, 2009.
29. D. Avramopoulos, N. C. Stefanis, I. Hantoumi, N. Smyrnis, I. Evdokimidis, and C. N. Stefanis, "Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele," Molecular Psychiatry, vol. 7, no. 7, pp. 706-711, 2002.
30. N. C. Stefanis, J. van Os, D. Avramopoulos et al., "Variation in catechol-O-methyltransferase val 158 met genotype associated with schizotypy but not cognition: a population study in 543 young men," Biological Psychiatry, vol. 56, no. 7, pp. 510-515, 2004.
31. N. Smyrnis,D.Avramopoulos, I. Evdokimidis, C.N. Stefanis,H. Tsekou, and N. C. Stefanis, "Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men," Biological Psychiatry, vol. 61, no. 7, pp. 845-853, 2007.
32. F. Schürhoff, A. Szöke, F. Chevalier et al., "Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele," The American Journal of Medical Genetics, Part B:NeuropsychiatricGenetics, vol. 144, no. 1,pp. 64-68, 2007.
33. A. R. Docherty and S. R. Sponheim, "Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of schizophrenia patients," Journal of Abnormal Psychology, vol. 117, no. 4, pp. 788-798, 2008.
34. A. Ros-Morente, G. Rodriguez-Hansen, R. Vilagŕa-Ruiz, T. R. Kwapil, and N. Barrantes-Vidal, "Adaptation of the wisconsin scales of psychosis proneness to Spanish," Actas espãnolas de psiquiatŕa, vol. 38, no. 1, pp. 33-41, 2010.
35. L. J. Chapman, J. P. Chapman, and M. L. Raulin, "Body-image aberration in schizophrenia," Journal of Abnormal Psychology, vol. 87, no. 4, pp. 399-407, 1978.
36. M. Eckblad and L. J.Chapman, "Magical ideation as an indicator of schizotypy," Journal of Consulting and Clinical Psychology, vol. 51, no. 2, pp. 215-225, 1983.
37. M. Eckblad, L. Chapman, J. Chapman, and M. Mishlove, The Revised Social Anhedonia Scale (unpublished test copies), Department of Psychology, University of North Carolina, Greensboro, NC, USA, 1982.
38. L. J. Chapman, J. P. Chapman, and M. L. Raulin, "Scales for physical and social anhedonia," Journal of Abnormal Psychology, vol. 85, no. 4, pp. 374-382, 1976.
39. B. P. Winterstein, P. J. Silvia, T. R. Kwapil, J. C. Kaufman, R. Reiter-Palmon, and B.Wigert, "Brief assessment of schizotypy: developing short forms of the Wisconsin Schizotypy Scales," Personality and Individual Differences, vol. 51, no. 8, pp. 920-924, 2011.
40. A. Ros-Morente, R. Vilagrà-Ruiz, G. Rodŕguez-Hansen, J. Wigman, and N. Barrantes-Vidal, "Proceso de adaptacíon al castellano de la Escala de Evaluacíon Comunitaria de Experiencias Ps̈quicas (CAPE)," Actas Espãnolas Psiquiatr, vol. 39, no. 2, pp. 95-105, 2011.
41. M. Konings, M. Bak, M. Hanssen, J. van Os, and L. Krabbendam, "Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population," Acta Psychiatrica Scandinavica, vol. 114, no. 1, pp. 55-61, 2006.
42. S. Rodriguez, T. R. Gaunt, and I. N. M. Day, "Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies," The American Journal of Epidemiology, vol. 169, no. 4, pp. 505-514, 2009.
43. C. Chen, C. Chen, R. Moyzis et al., "Sex modulates the associations between the COMT gene and personality traits," Neuropsychopharmacology, vol. 36, no. 8, pp. 1593-1598, 2011.
44. A. B. Amstadter, L. MacPherson, F. Wang et al., "The relationship between risk-taking propensity and the COMT Val158Met polymorphism among early adolescents as a function of sex," Journal of Psychiatric Research, vol. 46, no. 7, pp. 940-945, 2012.
45. X. Goldberg, M. Fatjó-Vilas, S. Alemany, I. Nenadic, C. Gastó, and L. Fãnańas, "Gene-environment interaction on cognition: a twin study of childhood maltreatment and COMT variability," Journal of Psychiatric Research, vol. 47, no. 7, pp. 989-994, 2013.
46. X. Ma, J. Sun, J. Yao et al., "A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population," Psychiatry Research, vol. 153, no. 1, pp. 7-15, 2007.
47. C. Henquet, A. Rosa, L. Krabbendam et al., "An experimental study of catechol-O-methyltransferase Val158Met moderation of 9-tetrahydrocannabinol-induced effects on psychosis and cognition," Neuropsychopharmacology, vol. 31, no. 12, pp. 2748-2757, 2006.
48. S. Alemany, B. Arias, M. Fatjó-Vilas et al., "Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes," Acta Psychiatrica Scandinavica, vol. 129, no. 1, pp. 54-62, 2014.
49. H. Ramsay, I. Kelleher, P. Flannery et al., "Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample," PLoS ONE, vol. 8, no. 11,Article ID e79741, 2013.
50. C. H. Vinkers,W. A. van Gastel, C.D. Schubart et al., "The effect of childhoodmaltreatment and cannabis use on adult psychotic symptoms ismodified by theCOMTVal158Met polymorphism," Schizophrenia Research, vol. 150, no. 1, pp. 303-311, 2013.
51. M. F. Egan, T. E. Goldberg, B. S. Kolachana et al., "Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6917-6922, 2001.
52. A. Rosa, V. Peralta, M. J. Cuesta et al., "New evidence of association betweenCOMTgene and prefrontal neurocognitive function in healthy individuals fromsibling pairs discordant for psychosis," American Journal of Psychiatry, vol. 161, no. 6, pp. 1110-1112, 2004.
53. L. M. Laatikainen, T. Sharp, P. J. Harrison, and E.M. Tunbridge, "Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopaminemetabolism inmultiple brain regions," PLoS ONE, vol. 8, no. 4,Article ID e61839, 2013.
54. S. C. Godar and M. Bortolato, "Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission," Frontiers in Behavioral Neuroscience, vol. 8, article 71, 2014.
55. J. A. Gogos, M. Morgan, V. Luine et al., "Catechol-Omethyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 17, pp. 9991-9996, 1998.